Filing Details
- Accession Number:
- 0001209191-13-055724
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-06 16:22:04
- Reporting Period:
- 2013-12-04
- Filing Date:
- 2013-12-06
- Accepted Time:
- 2013-12-06 16:22:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1168197 | Liposcience Inc | LPDX | In Vitro & In Vivo Diagnostic Substances (2835) | 561879288 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1530868 | Duffy E. Mcdonald | C/O Liposcience, Inc. 2500 Sumner Boulevard Raleigh NC 27616 | Vice President, Hr | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-12-04 | 12,731 | $2.50 | 16,496 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-12-04 | 12,731 | $4.07 | 3,765 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2013-12-04 | 12,731 | $0.00 | 12,731 | $2.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2013-12-12 | No | 4 | M | Direct |
Footnotes
- Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $3.98 to $4.22 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The option vested over a period of four years, with 25% of the shares underlying the option vested on November 24, 2004, with the remainder vesting in 36 equal monthly installments thereafter.